Sathiya Maran

Dr. Sathiya Maran

Monash University Malaysia, Subang Jaya, Malaysia
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
AKAmanda Shen-Yee Kong
Amanda Shen-Yee Kong
SMSathiya Maran
Sathiya Maran
PYPolly Soo-Xi Yap
Polly Soo-Xi Yap
ELErin Lim
Erin Lim
SYShun Kai Yang
Shun Kai Yang
KLKok Song Lai
Kok Song Lai
The rapid evolution of antimicrobial resistance (AMR) has remained a major public health issue, reducing the efficacy of antibiotics and increasing the difficulty of treating infections. The discovery of novel antimicrobial agents is urgently needed to overcome the challenges created by AMR. Natural products such as plant extracts and essential oils (EOs) have been viewed as potential candidates to combat AMR due to their complex chemistry that carries inherent pro-oxidant and antioxidant properties. EOs and their constituents that hold pro-oxidant properties can induce oxidative stress by producing reactive oxygen species (ROS), leading to biological damage in target cells. In contrast, the antioxidant properties scavenge free radicals through offsetting ROS. Both pro-oxidant and antioxidant activities in EOs represent a promising strategy to tackle AMR. Thus, this review aimed to discuss how pro-oxidants and antioxidants in EOs may contribute to the mitigation of AMR and provided a detailed description of the challenges and limitations of utilizing them as a means to combat AMR.

15 June 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
AKAmanda Shen-Yee Kong
Amanda Shen-Yee Kong
KLKok Song Lai
Kok Song Lai
WCWan Hee Cheng
Wan Hee Cheng
JLJiun-Yan Loh
Jiun-Yan Loh
ELErin Lim
Erin Lim
SMSathiya Maran
Sathiya Maran
Cardiovascular disease (CVD) remains the leading cause of death globally, with unhealthy lifestyles today greatly increasing the risk. Over the decades, scientific investigation has been carried out on reactive oxygen species (ROS) and their resultant oxidative stress based on their changes made on biological targets such as lipids, proteins, and DNA. Since the existing clinical studies with antioxidants failed to provide relevant findings on CVD prediction, the focus has shifted towards recognition of oxidised targets as biomarkers to predict prognosis and response to accurate treatment. The identification of redox markers could help clinicians in providing risk stratification for CVD events beyond the traditional prognostic and diagnostic targets. This review will focus on how oxidant-related parameters can be applied as biomarkers for CVD based on recent clinical evidence.

Verified
Journal Article
Open access
PDF file
AKAmanda Shen-Yee Kong
Amanda Shen-Yee Kong
KLKok Song Lai
Kok Song Lai
ELErin Lim
Erin Lim
SSSivakumar Sivalingam
Sivakumar Sivalingam
JLJiun-Yan Loh
Jiun-Yan Loh
SMSathiya Maran
Sathiya Maran
Ischemic heart disease (IHD) constitutes the leading global cause of mortality and morbidity. Although significant progress has been achieved in the diagnosis, treatment, and prognosis of IHD, more robust diagnostic biomarkers and therapeutic interventions are still needed to circumvent the increasing incidence of IHD. MicroRNAs (miRNAs) are critical regulators of cardiovascular function and are involved in various facets of cardiovascular biology. While the knowledge of the role of miRNAs in IHD as diagnostic biomarkers has improved, research emphasis on how miRNAs can be effectively used for diagnosis and prognosis of IHD is crucial. This review provides an overview of the biology, therapeutic and diagnostic potential, as well as the caveats of using miRNAs in IHD based on existing research.

1 January 2013 in World Journal of Gastroenterology
Verified
Journal Article
Open access
SMSathiya Maran
Sathiya Maran
To identify genes associated with gastric precancerous lesions in Helicobacter pylori (H. pylori)-susceptible ethnic Malays. Twenty-three Malay subjects with H. pylori infection and gastric precancerous lesions identified during endoscopy were included as "cases". Thirty-seven Malay subjects who were H. pylori negative and had no precancerous lesions were included as "controls". Venous blood was collected for genotyping with Affymetrix 50K Xba1 kit. Genotypes with call rates < 90% for autosomal single nucleotide polymorphisms (SNPs) were excluded. For each precancerous lesion, associated SNPs were identified from Manhattan plots, and only SNPs with a χ² P value < 0.05 and Hardy Weinberg Equilibrium P value > 0.5 was considered as significant markers. Of the 23 H. pylori-positive subjects recruited, one sample was excluded from further analysis due to a low genotyping call rate. Of the 22 H. pylori-positive samples, atrophic gastritis only was present in 50.0%, complete intestinal metaplasia was present in 18.25%, both incomplete intestinal metaplasia and dysplasia was present in 22.7%, and dysplasia only was present in 9.1%. SNPs rs9315542 (UFM1 gene), rs6878265 (THBS4 gene), rs1042194 (CYP2C19 gene) and rs10505799 (MGST1 gene) were significantly associated with atrophic gastritis, complete intestinal metaplasia, incomplete metaplasia with foci of dysplasia and dysplasia, respectively. Allele frequencies in "cases" vs "controls" for rs9315542, rs6878265, rs1042194 and rs10505799 were 0.4 vs 0.06, 0.6 vs 0.01, 0.6 vs 0.01 and 0.5 vs 0.02, respectively. Genetic variants possibly related to gastric precancerous lesions in ethnic Malays susceptible to H. pylori infection were identified for testing in subsequent trials.

13 December 2012 in Journal of Digestive Diseases
Verified
Journal Article
Closed access
PDF file
SMSathiya Maran
Sathiya Maran
Yeong Yeh LeeYeong Yeh Lee
Yeong Yeh Lee
SXShu Hua Xu
Shu Hua Xu
MRMahendra Sundramoorthy Raj
Mahendra Sundramoorthy Raj
NMNoorizan Abdul Majid
Noorizan Abdul Majid
DGDavid Y. Graham
David Y. Graham

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SMSathiya Maran
Sathiya Maran
SFSiti Aisyah Faten
Siti Aisyah Faten
SLSwee-Hua Erin Lim
Swee-Hua Erin Lim
KLKok-Song Lai
Kok-Song Lai
WIWan Pauzi Wan Ibrahim
Wan Pauzi Wan Ibrahim
HTHuay Lin Tan
Huay Lin Tan
Background. The 22q11.2 deletion syndrome (22q11.2DS) is the most common form of deletion disorder in humans. Low copy repeats flanking the 22q11.2 region confers a substrate for nonallelic homologous recombination (NAHR) events leading to rearrangements which have been reported to be associated with highly variable and expansive phenotypes. The 22q11.2DS is reported as the most common genetic cause of congenital heart defects (CHDs). Methods. A total of 42 patients with congenital heart defects, as confirmed by echocardiography, were recruited. Genetic molecular analysis using a fluorescence in situ hybridization (FISH) technique was conducted as part of routine 22q11.2DS screening, followed by multiplex ligation‐dependent probe amplification (MLPA), which serves as a confirmatory test. Results. Two of the 42 CHD cases (4.76%) indicated the presence of 22q11.2DS, and interestingly, both cases have conotruncal heart defects. In terms of concordance of techniques used, MLPA is superior since it can detect deletions within the 22q11.2 locus and outside of the typically deleted region (TDR) as well as duplications. Conclusion. The incidence of 22q11.2DS among patients with CHD in the east coast of Malaysia is 0.047. MLPA is a scalable and affordable alternative molecular diagnostic method in the screening of 22q11.2DS and can be routinely applied for the diagnosis of deletion syndromes.